Paper2831987
Studies on the interaction of 4-quinolones with DNA by DNA unwinding experiments.
Tornaletti S and 1 other. Biochim Biophys Acta, 1988. Cited by 57 papers, by iCite.
Cite this record
ConductScience Library. Studies on the interaction of 4-quinolones with DNA by DNA unwinding experiments. Papers, record 2831987. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2831987
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA, Circular | Major topic |
| Nalidixic Acid | Major topic |
| Norfloxacin | Major topic |
| Nucleic Acid Conformation | Major topic |
| Chloroquine | |
| DNA, Superhelical | |
| Topoisomerase II Inhibitors |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33271787 | Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance. | Molecules | 2020 | https://conductscience.org/library/papers/33271787 | PubMed |
| 26545354 | Synthesis, characterization, DNA interactions, DNA cleavage, radical scavenging activity, antibacterial, anti-proliferative and docking studies of new transition metal complexes. | J Fluoresc | 2016 | https://conductscience.org/library/papers/26545354 | PubMed |
| 22126453 | Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance. | Biochemistry | 2012 | https://conductscience.org/library/papers/22126453 | PubMed |
| 16341784 | Studies on interaction of norfloxacin, Cu2+, and DNA by spectral methods. | J Fluoresc | 2005 | https://conductscience.org/library/papers/16341784 | PubMed |
| 15649022 | The interaction between levofloxacine hydrochloride and DNA mediated by Cu2+. | J Fluoresc | 2004 | https://conductscience.org/library/papers/15649022 | PubMed |
| 15155208 | Ciprofloxacin dimers target gyrase in Streptococcus pneumoniae. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/15155208 | PubMed |
| 12604512 | Quinolone-DNA interaction: sequence-dependent binding to single-stranded DNA reflects the interaction within the gyrase-DNA complex. | Antimicrob Agents Chemother | 2003 | https://conductscience.org/library/papers/12604512 | PubMed |
| 12019094 | Quinolone-binding pocket of DNA gyrase: role of GyrB. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/12019094 | PubMed |
| 8962066 | Conversion of DNA gyrase into a conventional type II topoisomerase. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8962066 | PubMed |
| 8127667 | The ultimate carcinogen of 4-nitroquinoline 1-oxide does not react with Z-DNA and hyperreacts with B-Z junctions. | Nucleic Acids Res | 1994 | https://conductscience.org/library/papers/8127667 | PubMed |
| 7695267 | Effect of magnesium complexation by fluoroquinolones on their antibacterial properties. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/7695267 | PubMed |
| 2802562 | Interaction of the fluoroquinolone antimicrobial agents ciprofloxacin and enoxacin with liposomes. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2802562 | PubMed |
| 2556075 | Use of in vitro topoisomerase II assays for studying quinolone antibacterial agents. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2556075 | PubMed |
| 2548439 | Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2548439 | PubMed |
| 2510591 | Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2510591 | PubMed |
| 2327755 | Ciprofloxacin does not inhibit mitochondrial functions but other antibiotics do. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2327755 | PubMed |
| 2158270 | In vitro assays used to measure the activity of topoisomerases. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2158270 | PubMed |
| 1963290 | Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/1963290 | PubMed |
| 1723488 | Avian myeloblastosis virus reverse transcriptase inhibition by nalidixic acid. | Mol Cell Biochem | 1991 | https://conductscience.org/library/papers/1723488 | PubMed |
| 1409681 | Quinolone binding to DNA is mediated by magnesium ions. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1409681 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TOP2A | 7153 | PubTator's text mining | https://conductscience.org/library/genes/7153 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2831987
GET https://conductscience.org/api/papers/v1/2831987/authors